These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 26663190)

  • 41. MicroRNA regulation of melanoma progression.
    Bonazzi VF; Stark MS; Hayward NK
    Melanoma Res; 2012 Apr; 22(2):101-13. PubMed ID: 22209751
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The role of microRNAs in melanoma.
    Luo C; Weber CE; Osen W; Bosserhoff AK; Eichmüller SB
    Eur J Cell Biol; 2014; 93(1-2):11-22. PubMed ID: 24602414
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Detection of hair-microRNAs as the novel potent biomarker: evaluation of the usefulness for the diagnosis of scleroderma.
    Wang Z; Jinnin M; Kudo H; Inoue K; Nakayama W; Honda N; Makino K; Kajihara I; Fukushima S; Inoue Y; Ihn H
    J Dermatol Sci; 2013 Nov; 72(2):134-41. PubMed ID: 23890704
    [TBL] [Abstract][Full Text] [Related]  

  • 44. MicroRNA-150: A potential regulator in pathogens infection and autoimmune diseases.
    Huang XL; Zhang L; Li JP; Wang YJ; Duan Y; Wang J
    Autoimmunity; 2015; 48(8):503-10. PubMed ID: 26287504
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Identification of microRNA-31 as a novel regulator contributing to impaired interleukin-2 production in T cells from patients with systemic lupus erythematosus.
    Fan W; Liang D; Tang Y; Qu B; Cui H; Luo X; Huang X; Chen S; Higgs BW; Jallal B; Yao Y; Harley JB; Shen N
    Arthritis Rheum; 2012 Nov; 64(11):3715-25. PubMed ID: 22736314
    [TBL] [Abstract][Full Text] [Related]  

  • 46. MicroRNA-29: a potential therapeutic target for systemic sclerosis.
    Peng WJ; Tao JH; Mei B; Chen B; Li BZ; Yang GJ; Zhang Q; Yao H; Wang BX; He Q; Wang J
    Expert Opin Ther Targets; 2012 Sep; 16(9):875-9. PubMed ID: 22793265
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Aberrations in the micro-RNA biogenesis machinery and the emerging roles of micro-RNAs in the pathogenesis of cutaneous malignant melanoma.
    Leibowitz-Amit R; Sidi Y; Avni D
    Pigment Cell Melanoma Res; 2012 Nov; 25(6):740-57. PubMed ID: 22958787
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Is there a link between dysregulated miRNA expression and disease?
    Thai TH; Christiansen PA; Tsokos GC
    Discov Med; 2010 Sep; 10(52):184-94. PubMed ID: 20875339
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Genetic polymorphisms altering microRNA activity in psoriasis--a key to solve the puzzle of missing heritability?
    Pivarcsi A; Ståhle M; Sonkoly E
    Exp Dermatol; 2014 Sep; 23(9):620-4. PubMed ID: 24917490
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Identification of activated cytokine pathways in the blood of systemic lupus erythematosus, myositis, rheumatoid arthritis, and scleroderma patients.
    Higgs BW; Zhu W; Richman L; Fiorentino DF; Greenberg SA; Jallal B; Yao Y
    Int J Rheum Dis; 2012 Feb; 15(1):25-35. PubMed ID: 22324944
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Differential expression pattern of microRNAs in CD4+ and CD19+ cells from asymptomatic patients with systemic lupus erythematosus.
    Martínez-Ramos R; García-Lozano JR; Lucena JM; Castillo-Palma MJ; García-Hernández F; Rodríguez MC; Núñez-Roldán A; González-Escribano MF
    Lupus; 2014 Apr; 23(4):353-9. PubMed ID: 24509687
    [TBL] [Abstract][Full Text] [Related]  

  • 52. MicroRNAs: novel regulators in skin inflammation.
    Sonkoly E; Ståhle M; Pivarcsi A
    Clin Exp Dermatol; 2008 May; 33(3):312-5. PubMed ID: 18419608
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Novel insight into miRNA biology and its role in the pathogenesis of systemic lupus erythematosus.
    Luo B; Zhou K; Liufu Y; Huang X; Zeng H; Zhang Z
    Front Immunol; 2022; 13():1059887. PubMed ID: 36532020
    [TBL] [Abstract][Full Text] [Related]  

  • 54. miR-150 down-regulation contributes to the constitutive type I collagen overexpression in scleroderma dermal fibroblasts via the induction of integrin β3.
    Honda N; Jinnin M; Kira-Etoh T; Makino K; Kajihara I; Makino T; Fukushima S; Inoue Y; Okamoto Y; Hasegawa M; Fujimoto M; Ihn H
    Am J Pathol; 2013 Jan; 182(1):206-16. PubMed ID: 23159943
    [TBL] [Abstract][Full Text] [Related]  

  • 55. MicroRNAs in melanoma biology.
    Kunz M
    Adv Exp Med Biol; 2013; 774():103-20. PubMed ID: 23377970
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Down-regulation of miR-223 contributes to the formation of Gottron's papules in dermatomyositis via the induction of PKCɛ.
    Inoue K; Jinnin M; Yamane K; Makino T; Kajihara I; Makino K; Honda N; Nakayama W; Fukushima S; Ihn H
    Eur J Dermatol; 2013 Apr; 23(2):160-7. PubMed ID: 23557915
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The downregulation of microRNA let-7a contributes to the excessive expression of type I collagen in systemic and localized scleroderma.
    Makino K; Jinnin M; Hirano A; Yamane K; Eto M; Kusano T; Honda N; Kajihara I; Makino T; Sakai K; Masuguchi S; Fukushima S; Ihn H
    J Immunol; 2013 Apr; 190(8):3905-15. PubMed ID: 23509348
    [TBL] [Abstract][Full Text] [Related]  

  • 58. MicroRNA-29, a key regulator of collagen expression in systemic sclerosis.
    Maurer B; Stanczyk J; Jüngel A; Akhmetshina A; Trenkmann M; Brock M; Kowal-Bielecka O; Gay RE; Michel BA; Distler JH; Gay S; Distler O
    Arthritis Rheum; 2010 Jun; 62(6):1733-43. PubMed ID: 20201077
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The function of microRNAs in renal development and pathophysiology.
    Ma L; Qu L
    J Genet Genomics; 2013 Apr; 40(4):143-52. PubMed ID: 23618397
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Gender-specific medicine and dermatology: clinical implications.
    Mercurio MG
    J Gend Specif Med; 2000 Oct; 3(7):23-8. PubMed ID: 11252924
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.